Tin tức & Cập nhật

Which factors improve survival in ICI-treated patients with NSCLC?
Which factors improve survival in ICI-treated patients with NSCLC?
25 Apr 2023

The survival benefit derived from using immune checkpoint inhibitors (ICIs) is more evident in patients with advanced nonsmall cell lung cancer (NSCLC) who received first-line therapy, showed low neutrophil/lymphocyte ratio (NLR), and had no history of hormone use following initial treatment, suggests a recent study.

Which factors improve survival in ICI-treated patients with NSCLC?
25 Apr 2023
What are the risk factors for relapse after methotrexate dose reduction?
What are the risk factors for relapse after methotrexate dose reduction?
25 Apr 2023

For patients with rheumatoid arthritis, a history of cardiovascular disease, gastrointestinal disease, or liver disease, as well as prior use of nonsteroidal anti-inflammatory drugs can contribute to an increased risk of relapse after methotrexate dose reduction, as suggested in a study.

What are the risk factors for relapse after methotrexate dose reduction?
25 Apr 2023
Psilocybin shows therapeutic potential for depression
Psilocybin shows therapeutic potential for depression
24 Apr 2023

For cancer patients with depression, treatment with a single dose of psilocybin appears to yield rapid and meaningful improvements in depressive symptoms, as shown in a phase II study.

Psilocybin shows therapeutic potential for depression
24 Apr 2023